PANCREATIC ADENOCARCINOMA

This study tested several different combinations of immunotherapy drugs for people with metastatic pancreatic cancer that has spread. It involved 341 participants who had either received no prior treatment or one prior treatment. The main goals were to see if the drug combination…

This study compared two surgical approaches for removing pancreatic and nearby tumors: traditional open surgery versus newer robotic-assisted surgery. Researchers followed 268 patients across multiple hospitals in China to see if the robotic method was at least as good as open su…

This large, completed study tested whether adding a targeted drug (erlotinib) to standard chemotherapy, or adding radiation therapy after chemotherapy, could help patients live longer after surgery for pancreatic cancer. It involved 546 adults whose pancreatic tumors were surgica…

This study tested a new type of cell therapy called CTX131 for adults with advanced solid tumors that have returned or stopped responding to standard treatments. CTX131 uses a patient's own immune cells that are genetically modified in a lab to better target and fight cancer cell…

This study tested a two-step treatment for advanced pancreatic cancer. First, patients received standard chemotherapy plus experimental drugs designed to make cancer cells more vulnerable. If their disease was controlled after three cycles, they moved to a second phase receiving …

This study tested whether adding immunotherapy drugs (ipilimumab or nivolumab) to the cancer drug niraparib could help control advanced pancreatic cancer. It involved 104 patients whose cancer had initially responded to platinum-based chemotherapy but hadn't gotten worse. Researc…

This study tested whether a blood test could help diagnose pancreatic cancer. Researchers compared a new blood test that looks for cancer cells in the bloodstream against the standard biopsy procedure. The goal was to see if the blood test could provide accurate diagnosis with le…

This study tested whether an artificial intelligence (AI) model could predict how pancreatic cancer patients will fare after surgery and chemotherapy. Researchers trained the AI using pre-surgery CT scans and post-surgery tissue samples from 247 patients. The goal is to create a …

This study tested whether doctors could safely take small samples of a patient's pancreatic cancer tumor and grow miniature 3D versions (organoids) in the lab. Researchers then used these mini-tumors to test which chemotherapy drugs worked best against that specific patient's can…

This study tested a new method to collect and analyze cancer cells from the blood of pancreatic cancer patients. During a standard diagnostic procedure, doctors took an extra blood sample from a specific vein near the liver to see if the cancer cells found there could help predic…